SEC Form D · filed May 23, 2019
Neogene Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (14)
Helen S. Kim · New York, NYDirectorDavid M. Tanen · New York, NYDirector · PromoterAntonius N. Schumacher · New York, NYDirectorCarsten Linnemann, Phd · New York, NYExec · Director · PromoterGirehban Capital GP LLC · Brooklyn, NYDirectorNick Etherington · Salt Lake City, UTExec · Director · PromoterMarshall C. Greenbaum · Stamford, CTDirector · PromoterGirehban Capital LLC · Brooklyn, NYDirectorFei M. Chen · New York, NYDirectorChristian R. Daher · New York, NYDirector · PromoterSy Jacobs · NEW YORK, NYExec · Director · PromoterAsm Connaught House General Partner Iii Limited · Hong Kong, Hong KongDirectorArgyle Street Management Limited · Hong Kong, Hong KongDirectorFei M. Chen · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗